Seattle, May 22, 2013 - Cardeas Pharma Corporation, a biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial infections, ...
Treatment of lung diseases with inhaled medications is a challenge for mechanically ventilated patients, especially for the youngest ones. Therapeutic effects are thought to be limited by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback